New analyses of Neuropsychiatric Inventory (NPI) subdomain data showed significant benefits in agitation/aggression, disinhibition, elation/euphoria, and apathy after 48 weeks of treatment compared with placebo ... - 430 p.m (Abstract #12934) ... 21% ... .
Single-dose IBIO-610 achieved up to 98% inhibition of active Activin E through eight weeks, supporting a differentiated, long-acting antibody approach ... .
iBio Reports SingleDose of IBIO-610 Achieved Near-Complete ActiveActivin E Inhibition Through Eight Weeks in Obese NHPStudy... This level of inhibition supports the potential for low-frequency dosing to improve the patient experience.
The platform, reported June 23 in the Proceedings of the National Academy of Sciences, was demonstrated to inhibit cancer cells, lung inflammation and Parkinson's disease... inhibit Parkinson's disease.